Contract Option Exercises — March 06, 2026

Lockheed Martin ($2.87B + $248M) and others total ~$3.4B in space components/propulsion, affirming prime contractor status despite ended periods.

General Matter's $900M (up to $1.135B options) DOE award establishes 10-year domestic nuclear fuel revenue stream.

Optum ($724M VA), General Dynamics ($146M HHS), Deloitte ($86M + $66M) secure $1B+ in managed care/IT support through 2027+.

Leidos ($123M to $331M pot.), ManTech ($116M + $154M to $623M pot.), Palantir ($145M) gain Army/DHS/GSA IT work to 2029.

$0 outlayed on 12 contracts (60%) despite $4.5B+ obligations, including Lockheed $2.87B, signals funding delays or data lags.

Firm fixed price on 11 contracts (~$2.3B) exposes to cost overruns/inflation, e.g., Pernix construction to 2027, General Matter HALEU.

High subawards (e.g., Leidos $134M/39 subs, General Dynamics $177M/119 subs) pressure prime margins on $500M+ obligations.

Historical NASA contracts (6 total, ends 2004-2013) with $0 outlays limit current relevance amid new competitions.

$2.5B+ in unexercised options across contracts (e.g., ManTech $507M, Leidos $208M, General Dynamics $331M).

Long-duration contracts (10 to 2041, e.g., Ameresco 25yrs $101M pot., General Matter 10yrs) for energy/IT sustain recurring revenue.

Follow-on potential from flagship wins like Pernix Lagos Consulate, SES CBP aircraft, Palantir ICE case mgmt.

NASA obligations >50% of total ($3.4B across 6 contracts) underscore entrenched primes despite age.

DOE's $900M HALEU award signals policy-driven domestic capacity amid global supply risks.

12 IT/health contracts ($1.7B) with extensions to 2029+ reflect sticky federal demand.

{"entity"=>"Lockheed Martin", "reason"=>"$3.1B NASA (45% total value) but $0 outlay/ended periods warrant funding clarity.", "trigger"=>"outlay >$100M or new space awards"}

{"entity"=>"General Matter", "reason"=>"$900M HALEU small biz win positions for nuclear boom; execution key over 10yrs.", "trigger"=>"first HALEU production milestone or options exercise"}

{"entity"=>"ManTech / Leidos", "reason"=>"$240M+ obligations with $1B pot. options in IT/engineering; subaward margins critical.", "trigger"=>"option exercises adding >$200M"}

{"entity"=>"Optum (UnitedHealth)", "reason"=>"$724M VA healthcare IT with full obligation provides FY26+ visibility.", "trigger"=>"outlays commence post-Mar 2026 award"}